Compare MCS & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCS | CLPT |
|---|---|---|
| Founded | 1935 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 676.9M | 554.2M |
| IPO Year | 1994 | 2009 |
| Metric | MCS | CLPT |
|---|---|---|
| Price | $21.87 | $16.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $23.33 | $20.00 |
| AVG Volume (30 Days) | 246.5K | ★ 892.6K |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.77 | N/A |
| Revenue | ★ $758,458,000.00 | $36,971,000.00 |
| Revenue This Year | $12.05 | $45.67 |
| Revenue Next Year | $3.15 | $19.51 |
| P/E Ratio | $28.36 | ★ N/A |
| Revenue Growth | 3.11 | ★ 17.78 |
| 52 Week Low | $12.85 | $8.27 |
| 52 Week High | $24.74 | $30.10 |
| Indicator | MCS | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 48.74 | 47.99 |
| Support Level | $14.96 | $12.87 |
| Resistance Level | $24.74 | $16.54 |
| Average True Range (ATR) | 0.74 | 1.18 |
| MACD | -0.35 | -0.40 |
| Stochastic Oscillator | 8.31 | 2.55 |
Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.